Suraksha Diagnostic has closed its trading window for all designated persons and their immediate relatives effective Wednesday, 01 July 2026. This restriction will remain in force until 48 hours after the declaration of the unaudited standalone and consolidated financial results for the quarter ended 30 June 2026. The measure is in accordance with the Company's Code of Conduct for regulating, monitoring, and reporting of trading by insiders, as mandated by the SEBI (Prohibition of Insider Trading) Regulations, 2015.

The closure has been communicated to all designated and connected persons to ensure compliance with insider trading norms. The specific date for the Board of Directors' meeting to consider and approve the financial results for the quarter ended 30 June 2026 will be intimated to the stock exchanges in due course.

Key Details

The information regarding the trading window closure and subsequent results declaration will be available on the company's official website.

Suraksha Diagnostic Limited announced the resignation of Ms. Mamta Jain from the position of Company Secretary & Compliance Officer and Key Managerial Personnel (KMP). The resignation, effective July 15, 2026, was tendered on June 9, 2026, and is attributed to personal reasons. The company confirmed there are no other material reasons for her departure.

The disclosure was made to BSE Limited and The National Stock Exchange of India Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company acknowledged her contributions during her tenure.

Resignation Details

The company provided specific details regarding the cessation of the role in a structured format as required by SEBI regulations.

Ms. Jain confirmed in her resignation letter that she will extend full cooperation to ensure a smooth transition of her responsibilities. The company has undertaken necessary statutory and regulatory filings regarding the change.